4-6 December 2018

London, UK

Tumour Models London - Enhancing the Translational Confidence of Models Based Research. Tumour Models London returns for its 7th year and takes a reinvigorated approach towards closing the translational gap between predictable preclinical validation and successful clinical development. The meeting will dive into how emerging and classical model systems continue to evolve the early-stage decision making to more effectively support the translation from bench to patient. With new speakers, fresh case studies, and a more interactive format to the meeting agenda, Tumour Models London remains the leading forum for translational and preclinical scientists to really challenge how we optimise IO and Oncology-based research. Merging its unique strategic focus and scientific quality of presentations, the event facilitates an environment of knowledge sharing and debate. Where other conferences require you sit and listen quietly, we’ve redesigned the meeting format to ensure interactivity throughout and make sure you’ll leave with actionable takeaways on model utility and applicability.
Find Out More

Secure Your Place

Tumour Models London returns for its 7th year and takes a reinvigorated approach towards closing the translational gap between predictable preclinical validation and successful clinical development. The meeting will dive into how emerging and classical model systems continue to evolve the early-stage decision making to more effectively support the translation from bench to patient. With new speakers, fresh case studies, and a more interactive format to the meeting agenda, Tumour Models London remains the leading forum for translational and preclinical scientists to really challenge how we optimise IO and Oncology-based research. Merging its unique strategic focus and scientific quality of presentations, the event facilitates an environment of knowledge sharing and debate. Where other conferences require you sit and listen quietly, we’ve redesigned the meeting format to ensure interactivity throughout and make sure you’ll leave with actionable takeaways on model utility and applicability.

Tumour Models London returns for its 7th year while taking a reinvigorated approach towards closing the translational gap between predictable preclinical validation and successful clinical development.

The meeting will dive into how emerging and classical model systems continue to evolve the early-stage decision making to more effectively support the translation from bench to patient.

With new speakers, fresh case studies, and a more interactive format to the meeting agenda, Tumour Models London remains the leading forum for translational and preclinical scientists to really challenge how we optimise IO and Oncology-based research.

The key questions at the heart of the Tumour Models Series: 

  1. What new model and related technology initiatives are helping biopharma leaders drive translational and early-stage decision making

  2. How biopharma leaders are balancing the need for model complexity and relevance with time, throughput and cost

  3. What are the key criteria the leading biotech and pharma use to assess, select and characterise the array of tumour models

 


Highlights from Tumour Models London 2017

 

Media Partner